Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Curelator Headache Presents New Data Underscoring Misconceptions About Migraine Triggers And Protectors At American Headache Society Scientific Meeting (June 8-11)
  • USA - English


News provided by

Curelator Inc

Jun 09, 2017, 09:45 ET

Share this article

Share toX

Share this article

Share toX

Curelator Headache guides individuals with migraine headaches to identify their personal triggers, dismiss irrelevant factors, and discover protectors.
Curelator Headache guides individuals with migraine headaches to identify their personal triggers, dismiss irrelevant factors, and discover protectors.

Boston, MA (PRWEB) June 09, 2017 -- Curelator Headache™, the digital healthcare application pioneering "individualized trigger and protector mapping" for people with migraine, is presenting new data from ongoing studies in four posters at the 59th Annual Scientific Meeting of the American Headache Society in Boston (June 8-11).

Out of the 488 individuals participating in three trigger association studies, 391 (80%) were classified as having episodic migraine and 97 (20%) with chronic migraine, meaning 15 or more attacks per month. The mean age was 43.0 years and the majority (90%) were female.

These results suggest that if we condemn tyramine as a migraine trigger, we should point out that it potentially acts as a protector in a number of people.

Post this

Overall, individuals each suspected between 3 and 44 different migraine triggers, with varying degrees of certainty. Of suspected self-reported triggers, on average only 2.7 (11.5%) per individual were shown to be statistically associated with migraine attack occurrence. A further 14.2 (61%) were shown to have no statistical association with attacks and for 5.1 (22%) there was not enough data to determine an association.

“Our study results show that people with migraine have great difficulty identifying their personal triggers and their suspicions may be overly influenced by beliefs popularized on the internet. Unfortunately, these misperceptions lead to a lower quality of life by people avoiding many things they love but without good scientific reason,” explains Alec Mian, CEO and founder of Curelator Inc.

The first study examined trigger suspicions in users with episodic vs. chronic migraine and revealed an unexpected disconnect between suspicions and scientific reality. Both groups suspected virtually the same set of triggers. However, after using Curelator Headache, which scientifically determines true risk factor associations, significant differences in triggers were revealed between episodic vs. chronic participants.

For example, Curelator analyzed associations of migraine attacks with tyramine, which was suspected as a risk factor by almost half of the individuals in the study. Tyramine is found in aged cheeses, pickled food, cured meat, soybean products, certain dried beans and overripe fruits, all of which are often avoided by people with migraine.

However, in a thorough analysis of tyramine intake, there was a very low statistical association with attacks (i.e., less than 10% with episodic migraine and less than 5% chronic migraine participants had a confirmed association). In an unexpected discovery, among the individuals who most strongly suspected tyramine as a trigger, tyramine was more commonly found to be associated with decreased risk (protectors) of migraine!

Dr. Mian adds, “These results suggest that if we condemn tyramine as a migraine trigger, we should point out that it potentially acts as a protector in a number of people.”

Curelator Headache will also be presenting new data on a fourth study with 477 participants on medication use and overuse patterns in people with migraine. Overall, potential overuse of acute medication was identified in 73 (29%) and 40 (19%) of US and UK patients, respectively.

The following posters are being presented in collaboration with leading headache specialists from Australia (Paul Martin, DPhil); the United Kingdom (Anne MacGregor MD, Peter J. Goadsby MD PhD); and the U.S. (Stephen Silberstein MD):

Comparison of self-reported triggers in individuals with episodic or chronic migraine
Stephen Donoghue PhD1, Gabriel Boucher BSc1, Francesc Peris PhD1, Alec Mian PhD1 and Paul R. Martin DPhil2
1Curelator Inc. Cambridge, MA, USA and 2School of Applied Psychology, Griffith University, Queensland, Australia

Self-reported triggers vs. those prospectively statistically determined in individuals with episodic and chronic migraine
Stephen Donoghue PhD1, Gabriel Boucher BSc1, Francesc Peris PhD1, Alec Mian PhD1 and Paul R. Martin DPhil2
1 Curelator Inc. Cambridge, MA, USA and 2School of Applied Psychology, Griffith University, Queensland, Australia

Tyramine as a risk factor for migraine attacks: an exploration
Stephen Donoghue PhD1, Gabriel Boucher BSc1, Francesc Peris PhD1, Alec Mian PhD1, Anne MacGregor MD2
1 Curelator Inc., Cambridge MA, USA and 2Barts and the London SMD, London, UK.

Medication use and overuse patterns in Curelator HeadacheTM US and UK users.
Pablo Prieto1, Gabriel Boucher1, and Stephen Donoghue1, Peter J. Goadsby2 and Stephen D. Silberstein3
1Curelator Inc. Cambridge, MA, USA, 2NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London, UK, 3Jefferson Headache Center, Thomas Jefferson University, Philadelphia, USA

Study participants registered to use Curelator Headache via the Company’s website or the App store (iOS only) after physician referral or self-referral. They then used Curelator Headache daily for 90 days, entering details about headaches and tracking factors that may affect migraine attack occurrence. After 90 days all factors were analyzed for each individual.

About Curelator Inc.
Curelator is a patient-centric digital platform that enables patients, clinicians and healthcare providers to optimize individual therapeutic pathways in chronic diseases with episodic attacks.

Contact for further information: Sandy Bodner, sbodner(at)curelator(dot)com, 617-549-8523

Sandy Bodner, Curelator Inc, http://www.curelator.com, +1 (617) 549-8523, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.